Funded Tech Companies
Edgewise Therapeutics
Edgewise Therapeutics, operating out of Boulder, received equity investments from OrbiMed, Deerfield Capital and New Leaf Venture Partners.
Company Overview
Company Name
Edgewise Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3415 Colorado Ave.
Boulder, CO 80304
USA
Boulder, CO 80304
USA
Phone
Website
Email Address
Company Background Information
Overview
Edgewise Therapeutics is a new company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/26/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Koch
Chief Financial Officer
Michael Carruthers
Chief Medical Officer
Kirsten Gruis
Chief Scientific Officer
Alan Russell
Vice President
Abby Bronson
VP - Bus. Development
Behrad Derakhshan
VP - General Counsel
John Moore
VP - Regulatory Affairs
Nicole Kilburn
Company Investors
- OrbiMed (Peter Thompson)
- Deerfield Capital (Robert Jackson)
- New Leaf Venture Partners
- U.S. Venture Partners (Jonathan Root)
- Wellington Management Company
- Novo Nordisk Biotech Fund
- Logos Capital
- RA Capital
- Viking Global Investors
- Cormorant Asset Management
- CureDuchenne Ventures
- Janus Henderson Investors
- Surveyor Capital
- Novo Ventures (Kenneth Harrison)
Browse more funded tech companies:
Edgewise Networks | Edgewood Oncology
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs